Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cells
Thomas W. Grunt(Comprehensive Cancer Center Vienna), Christian Dittrich(Kaiser-Franz-Josef-Spital), Georg Krupitza(Medical University of Vienna), Ruth Lupu(Mayo Clinic), H. Huber(University Hospital Innsbruck), Mary Beth Martin(Georgetown University), Hanna Harant(University of Vienna), E. Dittrich(University of Vienna), Miguel Saceda(Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana)
Cited by 70
Related Papers
Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland
|Nature Medicine|2003|581
Activation of Estrogen Receptor-α by the Heavy Metal Cadmium
|Molecular Endocrinology|2000|423
Estrogen-Like Activity of Metals in Mcf-7 Breast Cancer Cells
|Endocrinology|2003|409
Regulation of the Estrogen Receptor in MCF-7 Cells by Estradiol
|Molecular Endocrinology|1988|339
Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells
|Journal of Biological Chemistry|1994|327